EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Relationship between polygenic risk scores and symptom dimensions of schizophrenia and schizotypy in multiplex families with schizophrenia

Mohammad Ahangari iD, Daniel Bustamante, Robert Kirkpatrick, Tan-Hoang Nguyen, Brian C Verrelli, Ayman Fanous, Kenneth S Kendler, Bradley T Webb iD, Silviu-Alin Bacanu, Brien P Riley

The British Journal of Psychiatry · 2023

DOI: 10.1192/bjp.2022.179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The British Journal of Psychiatry, 2023. Verfasst von Mohammad Ahangari und 9 weiteren Autor:innen. Beteiligte Einrichtung: Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, USA; and Integrative Life Sciences PhD Program, Virgini…. Hauptthemen laut MEDLINE: Schizophrenia, Schizotypal Personality Disorder, Major Depressive Disorder, Psychotic Disorders. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, National Institute of Mental Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Psychotic disorders and schizotypal traits aggregate in the relatives of probands with schizophrenia. It is currently unclear how variability in symptom dimensions in schizophrenia probands and their relatives is associated with polygenic liability to psychiatric disorders.

Aims

To investigate whether polygenic risk scores (PRSs) can predict symptom dimensions in members of multiplex families with schizophrenia.

Method

The largest genome-wide data-sets for schizophrenia, bipolar disorder and major depressive disorder were used to construct PRSs in 861 participants from the Irish Study of High-Density Multiplex Schizophrenia Families. Symptom dimensions were derived using the Operational Criteria Checklist for Psychotic Disorders in participants with a history of a psychotic episode, and the Structured Interview for Schizotypy in participants without a history of a psychotic episode. Mixed-effects linear regression models were used to assess the relationship between PRS and symptom dimensions across the psychosis spectrum.

Results

Schizophrenia PRS is significantly associated with the negative/disorganised symptom dimension in participants with a history of a psychotic episode ( P = 2.31 × 10 −4 ) and negative dimension in participants without a history of a psychotic episode ( P = 1.42 × 10 −3 ). Bipolar disorder PRS is significantly associated with the manic symptom dimension in participants with a history of a psychotic episode ( P = 3.70 × 10 −4 ). No association with major depressive disorder PRS was observed.

Conclusions

Polygenic liability to schizophrenia is associated with higher negative/disorganised symptoms in participants with a history of a psychotic episode and negative symptoms in participants without a history of a psychotic episode in multiplex families with schizophrenia. These results provide genetic evidence in support of the spectrum model of schizophrenia, and support the view that negative and disorganised symptoms may have greater genetic basis than positive symptoms, making them better indices of familial liability to schizophrenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaSchizotypal Personality DisorderMajor Depressive DisorderPsychotic DisordersHumansRisk Factors

Stichwörter der Autor:innen

Schizophreniageneticsnegative symptomspsychotic disordersschizotypy

Autor:innen und Institutionen

  • Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, USA; and Integrative Life Sciences PhD Program, Virginia Commonwealth University, USA.
  • Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, USA; and Department of Psychiatry, Virginia Commonwealth University, USA.
  • Center for Biological Data Science, Virginia Commonwealth University, USA.
  • Department of Psychiatry, University of Arizona, USA.
  • Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, USA; Department of Psychiatry, Virginia Commonwealth University, USA; and Department of Human and Molecular Genetics, Virgini…
  • GenOmics, Bioinformatics, and Translational Research Center, Biostatistics and Epidemiology Division, RTI International, Research Triangle Park, USA.

ORCID-Profile: Mohammad Ahangari, Bradley T Webb

Förderung

  • NIMH NIH HHS
  • National Institute of Mental Health

Zitieren

APA

Ahangari, M., Bustamante, D., Kirkpatrick, R., Nguyen, T. H., Verrelli, B. C., Fanous, A., Kendler, K. S., Webb, B. T., Bacanu, S. A., & Riley, B. P. (2023). Relationship between polygenic risk scores and symptom dimensions of schizophrenia and schizotypy in multiplex families with schizophrenia. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.2022.179

Vancouver

Ahangari M, Bustamante D, Kirkpatrick R, Nguyen TH, Verrelli BC, Fanous A, et al. Relationship between polygenic risk scores and symptom dimensions of schizophrenia and schizotypy in multiplex families with schizophrenia. The British Journal of Psychiatry. 2023. doi:10.1192/bjp.2022.179

BibTeX
@article{Ahangari2023,
  author = {Ahangari, Mohammad and Bustamante, Daniel and Kirkpatrick, Robert and Nguyen, Tan-Hoang and Verrelli, Brian C and Fanous, Ayman and Kendler, Kenneth S and Webb, Bradley T and Bacanu, Silviu-Alin and Riley, Brien P},
  title = {Relationship between polygenic risk scores and symptom dimensions of schizophrenia and schizotypy in multiplex families with schizophrenia},
  journal = {The British Journal of Psychiatry},
  year = {2023},
  doi = {10.1192/bjp.2022.179}
}
Kostenlos starten →